Notably, the V600K mutation, which is associated with greater activation of the PIK3CA pathway and more aggressive CM behavior [5, 13], was detected in almost 10% of CM patients with BRAF mutations in Ukraine, which aligns with global statistics [14]. The gene discussed is BRAF; the disease is cutaneous mastocytosis.